Researchers at KAIST (Korea Advanced Institute of Science and Technology) have introduced a revolutionary technology for treating colon cancer without destroying cancer cells. Instead, this breakthrough method transforms cancer cells into a state resembling normal colon cells, significantly reducing harmful side effects.
This approach challenges conventional cancer treatments, which often involve risks of side effects, limitations, and remission. Led by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering, the research team explored oncogenesis (the process of cancer formation) and found that normal cells regress along their differentiation pathway—a process that determines how cells develop and specialize.
Using this insight, the team developed a digital twin of the gene network that controls cell differentiation. Through advanced simulation analysis, they identified key molecular "master switches" capable of reverting colon cancer cells to a more normal-like state. This pioneering method holds the potential to redefine cancer treatment by addressing its challenges in a novel and less invasive way.
